International Journal on Magnetic Particle Imaging IJMPI
Vol. 12 No. 1 Suppl 1 (2026): Int J Mag Part Imag
https://doi.org/10.18416/IJMPI.2026.2603010

Proceedings Articles, ID 1024

In vivo MPI/BLI tracking of genome-edited-patient derived neural precursor cells in a transgenic ALS mouse model

Main Article Content

Ali Shakeri-Zadeh (Johns Hopkins University), Asif Itoo (1The Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA 2Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA), Shreyas Kuddannaya (1The Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA 2Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA), Cristina Zivko (3Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.), Vasiliki Mahairaki (3Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.), Jeff Bulte (1The Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA 2Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA)

Abstract

Amyotrophic lateral sclerosis (ALS) caused by superoxide dismutase 1 (SOD1) mutations may benefit from a gene-edited induced pluripotent stem cell (iPSC)-based therapy, provided cell fate after administration can be monitored precisely, non-invasively and longitudinally for effective optimization. This study evaluated tracking of neural precursor cells (NPCs) derived from gene-edited iPSCs using magnetic particle imaging (MPI) and bioluminescence imaging (BLI). Luciferase-expressing Nanoluc-NPCs were magnetically labeled and stereotaxically transplanted into the motor cortex of SOD1G93A transgenic mouse models. BLI confirmed luciferase activity and cell viability, while MPI enabled quantitative tracking of labeled cells in vivo. Regression analysis estimated an iron content of ~10 pg per cell, with MPI-derived cell numbers aligning closely with injected values. BLI signals persisted for two weeks, and behavioral testing revealed delayed disease progression for treated vs. non-treated controls. These results demonstrate successful non-invasive visualization and quantification of transplanted NPCs, supporting the use of MPI/BLI for imaging-guided cell therapies in ALS.

Article Details

References

[1] E. Kiskinis, et al., Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1, Cell Stem Cell. 2014;14(6):781-95.
[2] J.W.M. Bulte, et al., Quantitative “hot-spot” imaging of transplanted stem cells using superparamagnetic tracers and magnetic particle imaging. Tomography. 2015;1(2):91-98.
[3] E. Aguera-Morales, et al., 1. Aguera-Morales E, Fernández Sánchez VE, Navarro Mascarell G, Cabezas Rodríguez JA, Peña Toledo MÁ, Reyes Garrido V, et al. Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial. Frontiers in Neurology. 2025;16:1655124.
[4] A. Srivastava, et al., Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology. 2017;289:96-102.

Most read articles by the same author(s)